<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Celgene Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Mark J. Alles
    • FOUNDED
      1986
    • EMPLOYEES
      5001-10000
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Celsion Corporation

    Celsion Corporation

    Celsion Corporation is a fully integrated biopharmaceutical company focused on dev...

    Celsion Corporation is a fully integrated bioph...

    Filing Type:    PU
    Semler Scientific, Inc.

    Semler Scientific, Inc.

    Semler Scientific, Inc. is an emerging medical risk-assessment company whose diagn...

    Semler Scientific, Inc. is an emerging medical ...

    Filing Type:    PU
    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the deve...

    Citius Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    ZENII, LLC

    ZENII, LLC

    Intrommune Therapeutics is a New York City-based biopharmaceutical company develop...

    Intrommune Therapeutics is a New York City-base...

    Amount Raised:    $154,555.00
    Fundraising Status:    EC
    Filing Type:    CF
    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical...

    Neurocrine Biosciences (Nasdaq: NBIX) is a neur...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Athenex, Inc.

    Athenex, Inc.

    Athenex is a global oncology focused biopharmaceutical company dedicated to the di...

    Athenex is a global oncology focused biopharmac...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee we’re fundamentally changing not only the way cancer is detected but also...

    At Delee we’re fundamentally changing not only ...

    Amount Raised:    $492,503.00
    Fundraising Status:    EC
    Filing Type:    CF
    ViewRay, Inc.

    ViewRay, Inc.

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdianÂŽ the wor...

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufac...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Dynavax Technologies Corporation

    Dynavax Technologies Corporation

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceuti...

    Dynavax Technologies Corporation (Nasdaq: DVAX)...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.